Anthony L. DeVico

11.6k citations

105 papers · 7.2k indexed · 2 hit papers · h-index 37

Impact in

Virology top 0.05%
- HIV Research and Treatment
Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in ⓘ

Virology 90
- HIV Research and Treatment 89
Immunology 77
- Immune Cell Function and Interaction 57
- T-cell and B-cell Immunology 20
- T-cell and Retrovirus Studies 9

Co-authors: Robert C. Gallo (37 shared papers)Alfredo Garzino‐Demo (14 shared papers)Paolo Lusso (5 shared papers)Fiorenza Cocchi (9 shared papers)Suresh K. Arya (2 shared papers)George K. Lewis (49 shared papers)Terry D. Copeland (4 shared papers)Stephen Oroszlan (3 shared papers)
Journals: Proceedings of the National Academy of Sciences (14 papers)Journal of Virology (14 papers)AIDS Research and Human Retroviruses (8 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (7 papers)Science (6 papers)
Partner nations: United States Nigeria Italy

In The Last Decade

Anthony L. DeVico

104 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 ⁺ T Cells 1995 · 2.4k citations

Peers

Countries citing papers authored by Anthony L. DeVico

Since Specialization

Citations

This map shows the geographic impact of Anthony L. DeVico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony L. DeVico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony L. DeVico more than expected).

Fields of papers citing papers by Anthony L. DeVico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony L. DeVico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony L. DeVico. The network helps show where Anthony L. DeVico may publish in the future.

Co-authors

The 25 scholars most cited alongside Anthony L. DeVico, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anthony L. DeVico Line = papers co-authored together Anthony L. DeVico links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 ⁺ T Cells Science ·Fiorenza Cocchi, Anthony L. DeVico, Alfredo Garzino‐Demo, Suresh K. Arya, Robert C. Gallo, Paolo Lusso Hit paper breakdown →	1995	2364
2	Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV Science ·Fulvia Veronese, Terry D. Copeland, Anthony L. DeVico, Rukhsana Rahman, Stephen Oroszlan, Robert C. Gallo, M. G. Sarngadharan Hit paper breakdown →	1986	487
3	The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection Nature Medicine ·Florenza Cocchi, Anthony L. DeVico, Alfredo Garzino‐Demo, Andrea Cara, Robert C. Gallo, Paolo Lusso	1996	434
4	Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene Science ·Fulvia DiMarzo Veronese, Anthony L. DeVico, Terry D. Copeland, Stephen Oroszlan, Robert C. Gallo, M. G. Sarngadharan	1985	387
5	Identification of a Major Growth Factor for AIDS-Kaposi's Sarcoma Cells as Oncostatin M Science ·Bala C. Nair, Anthony L. DeVico, Shuji Nakamura, Terry D. Copeland, Ying Chen, Atul Patel, Trevor O'Neil, Stephen Oroszlan, Robert C. Gallo, M. G. Sarngadharan	1992	189
6	Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro. Proceedings of the National Academy of Sciences ·Hiroaki Mitsuya, Ruth F. Jarrett, Makoto Matsukura, Fulvia Veronese, Anthony L. DeVico, M. G. Sarngadharan, David G. Johns, M S Reitz, S Broder	1987	178
7	Inhibition of HIV-1 Infection by the β-Chemokine MDC Science ·(unknown), Alfredo Garzino‐Demo, (unknown), Jennifer M. Burns, Michelle Brown, Robert C. Gallo, Anthony L. DeVico	1997	147
8	Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. Molecular Pharmacology ·Hao Zhang, David A. Cooney, Neil R. Hartman, Carlo Federico Perno, Arnold Fridland, Anthony L. DeVico, M. G. Sarngadharan, S Broder, D G Johns	1988	143
9	Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding Proceedings of the National Academy of Sciences ·Yongjun Guan, Marzena Pazgier, Mohammad M. Sajadi, Roberta Kamin‐Lewis, Salma Al-Darmarki, Robin Flinko, Elena Lovo, Xueji Wu, James E. Robinson, Michael S. Seaman, Timothy Fouts, Robert C. Gallo, Anthony L. DeVico, George K. Lewis	2012	117
10	Higher macrophage inflammatory protein (MIP)-1α and MIP-1β levels from CD8⁺T cells are associated with asymptomatic HIV-1 infection Proceedings of the National Academy of Sciences ·Fiorenza Cocchi, Anthony L. DeVico, Robert Yarchoan, Robert R. Redfield, Farley Cleghorn, William A. Blattner, Alfredo Garzino‐Demo, Sandra Colombini-Hatch, David M. Margolis, Robert C. Gallo	2000	115
11	Spontaneous and antigen-induced production of HIV-inhibitory β-chemokines are associated with AIDS-free status Proceedings of the National Academy of Sciences ·Alfredo Garzino‐Demo, Ronald B. Moss, Joseph B. Margolick, Farley Cleghorn, Anne Sill, William A. Blattner, Fiorenza Cocchi, Dennis J. Carlo, Anthony L. DeVico, Robert C. Gallo	1999	103
12	Expression and Characterization of a Single-Chain Polypeptide Analogue of the Human Immunodeficiency Virus Type 1 gp120-CD4 Receptor Complex Journal of Virology ·Timothy Fouts, Robert G. Tuskan, Karla Godfrey, Marvin S. Reitz, David M. Hone, George K. Lewis, Anthony L. DeVico	2000	96
13	Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques Proceedings of the National Academy of Sciences ·Timothy Fouts, Karla Godfrey, Kathryn Bobb, David C. Montefiori, Carl V. Hanson, V. S. Kalyanaraman, Anthony L. DeVico, Ranajit Pal	2002	92
14	Control of HIV-1 infection by soluble factors of the immune response Nature Reviews Microbiology ·Anthony L. DeVico, Robert C. Gallo	2004	85
15	Human neutrophil α‐defensin 4 inhibits HIV‐1 infection in vitro FEBS Letters ·Zhibin Wu, Fiorenza Cocchi, David Gentles, Bryan Ericksen, J. Łubkowski, Anthony L. DeVico, Robert I. Lehrer, Wuyuan Lu	2004	84
16	Characterization of the Secreted, Native gp120 and gp160 of the Human Immunodeficiency Virus Type 1 AIDS Research and Human Retroviruses ·Vaniambadi S. Kalyanaraman, Valerie Rodriguez, Fulvia Veronese, Rukhsana Rahman, Paolo Lusso, Anthony L. DeVico, T D Copeland, Stephen Oroszlan, Robert C. Gallo, M. G. Sarngadharan	1990	70
17	Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro Biochemistry ·Christian Stein, Ranajit Pal, Anthony L. DeVico, George Hoke, S. Mumbauer, Olaf Kinstler, M. G. Sarngadharan, Robert L. Letsinger	1991	69
18	Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens Proceedings of the National Academy of Sciences ·Anthony L. DeVico, Timothy Fouts, George K. Lewis, Robert C. Gallo, Karla Godfrey, Manhattan Charurat, Ilia Harris, Lindsey Galmin, Ranajit Pal	2007	65
19	Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses Cell ·Mohammad M. Sajadi, Amir Dashti, Zahra Rikhtegaran Tehrani, William D. Tolbert, Michael S. Seaman, Xin Ouyang, Neelakshi Gohain, Marzena Pazgier, Dongkyoon Kim, Guy Cavet, Jean A. Yared, Robert Redfield, George K. Lewis, Anthony L. DeVico	2018	65
20	Antigenic Properties of the Human Immunodeficiency Virus Transmembrane Glycoprotein during Cell-Cell Fusion Journal of Virology ·Catherine M. Finnegan, Werner Berg, George K. Lewis, Anthony L. DeVico	2002	60

About Anthony L. DeVico

Anthony L. DeVico is a scholar working on Virology, Immunology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 105 papers that have together received 7.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (89 papers), Immune Cell Function and Interaction (57 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), HIV/AIDS drug development and treatment (25 papers), T-cell and B-cell Immunology (20 papers), Glycosylation and Glycoproteins Research (9 papers), T-cell and Retrovirus Studies (9 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Virology (5.2k citations), Immunology (3.9k citations), Infectious Diseases (2.4k citations), Epidemiology (1.3k citations) and Microbiology (222 citations). Anthony L. DeVico has collaborated with scholars based in United States, Nigeria and Italy. Frequent co-authors include Robert C. Gallo, Alfredo Garzino‐Demo, Paolo Lusso, Fiorenza Cocchi, Suresh K. Arya, George K. Lewis, Terry D. Copeland, Stephen Oroszlan, M. G. Sarngadharan and Fulvia Veronese. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Virology, AIDS Research and Human Retroviruses, JAIDS Journal of Acquired Immune Deficiency Syndromes and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact